Close
Exscientia presented its innovative use of AI and robotics to streamline drug discovery at the ELRIG Drug Discovery 2024 meeting. The company highlighted a significant increase in AI-designed molecules entering clinical trials, boasting an impressive 80% success rate in Phase I trials compared to the industry average of 15%. This advancement is attributed to Exscientia's flexible automated systems that can conduct a variety of assays efficiently.
The unveiling of a 26,000ft robotic laboratory in Oxfordshire marks a significant milestone for Exscientia, showcasing its commitment to integrating AI in drug development. The company emphasizes that AI is not intended to replace human roles but to enhance productivity and efficiency in the drug discovery process. With increasing investments in AI-driven biotech, the future of healthcare is poised for transformation, as evidenced by the $1.2 billion deal with Bristol-Myers Squibb.
• AI-designed molecules show an 80% Phase I success rate.
• Exscientia's robotic lab enhances drug discovery efficiency.
Exscientia's approach automates the drug discovery process, significantly increasing the number of viable candidates entering clinical trials.
Exscientia's robotic laboratory exemplifies how robotics can streamline complex assays in drug development.
The flexibility of Exscientia's automated assays allows for rapid testing of various drug targets.
Exscientia's innovative use of AI has led to the design of multiple drug candidates with reduced human intervention.
The company partnered with Exscientia in a $1.2 billion deal to leverage AI in drug discovery.
Phys.org on MSN.com 15month
The Conversation on MSN.com 10month
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.
Log in
Sign Up
AI Tools - Popular
AI Tools - Categories
GPTs - Categories
AI for Jobs
Key AI Highlights in this Article
Key AI Terms Mentioned in this Article
Companies Mentioned in this Article
